- Home
- VOR vs STIM Comparison
VOR vs STIM Comparison
Compare VOR & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- STIM
- Stock Information
- Founded
- VOR 2015
- STIM 2003
- Country
- VOR United States
- STIM United States
- Employees
- VOR N/A
- STIM N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- VOR Health Care
- STIM Health Care
- Exchange
- VOR Nasdaq
- STIM Nasdaq
- Market Cap
- VOR 261.0M
- STIM 224.8M
- IPO Year
- VOR 2021
- STIM 2018
- Fundamental
- Price
- VOR $1.57
- STIM $2.77
- Analyst Decision
- VOR Buy
- STIM Strong Buy
- Analyst Count
- VOR 6
- STIM 2
- Target Price
- VOR $3.90
- STIM $7.00
- AVG Volume (30 Days)
- VOR 4.4M
- STIM 1.6M
- Earning Date
- VOR 11-06-2025
- STIM 11-11-2025
- Dividend Yield
- VOR N/A
- STIM N/A
- EPS Growth
- VOR N/A
- STIM N/A
- EPS
- VOR N/A
- STIM N/A
- Revenue
- VOR N/A
- STIM $111,106,000.00
- Revenue This Year
- VOR N/A
- STIM $105.70
- Revenue Next Year
- VOR N/A
- STIM $11.77
- P/E Ratio
- VOR N/A
- STIM N/A
- Revenue Growth
- VOR N/A
- STIM 54.17
- 52 Week Low
- VOR $0.13
- STIM $0.52
- 52 Week High
- VOR $3.29
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- VOR 33.31
- STIM 33.48
- Support Level
- VOR $1.80
- STIM $3.00
- Resistance Level
- VOR $2.03
- STIM $3.71
- Average True Range (ATR)
- VOR 0.13
- STIM 0.27
- MACD
- VOR -0.05
- STIM -0.03
- Stochastic Oscillator
- VOR 10.30
- STIM 1.05
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.